Guest guest Posted January 24, 2009 Report Share Posted January 24, 2009 J Allergy Clin Immunol. 2008 Mar;121(3):626- 31. Epub 2008 Jan 18. J Allergy Clin Immunol. 2008 Sep;122(3):656; author reply 657-8. Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma. Mc KL, Huq SI, Lix LM, Becker AB, Kozyrskyj AL. Faculty of Medicine, Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. BACKGROUND: Early childhood immunizations have been viewed as promoters of asthma development by stimulating a T(H)2-type immune response or decreasing microbial pressure, which shifts the balance between T(H)1 and T(H)2 immunity. OBJECTIVE: Differing time schedules for childhood immunizations may explain the discrepant findings of an association with asthma reported in observational studies. This research was undertaken to determine whether timing of diphtheria, pertussis, tetanus (DPT) immunization has an effect on the development of childhood asthma by age 7 years. METHODS: This was a retrospective longitudinal study of a cohort of children born in Manitoba in 1995. The complete immunization and health care records of cohort children from birth until age 7 years were available for analysis. The adjusted odds ratio for asthma at age 7 years according to timing of DPT immunization was computed from multivariable logistic regression. RESULTS: Among 11, 531 children who received at least 4 doses of DPT, the risk of asthma was reduced to (1/2) in children whose first dose of DPT was delayed by more than 2 months. The likelihood of asthma in children with delays in all 3 doses was 0.39 (95% CI, 0.18-0.86). CONCLUSION: We found a negative association between delay in administration of the first dose of whole-cell DPT immunization in childhood and the development of asthma; the association was greater with delays in all of the first 3 doses. The mechanism for this phenomenon requires further research. PMID: 18207561 J Manipulative Physiol Ther. 2000 Feb;23(2):81- 90. Effects of diphtheria-tetanus- pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. Hurwitz EL, Morgenstern H. UCLA School of Public Health, Department of Epidemiology, Los Angeles, Calif 90095-1772, USA. ehurwitzucla (DOT) edu BACKGROUND: Findings from animal and human studies confirm that diphtheria and tetanus toxoids and pertussis (DTP) and tetanus vaccinations induce allergic responses; associations between childhood vaccinations and subsequent allergies have been reported recently. OBJECTIVE: The association of DTP or tetanus vaccination with allergies and allergy-related respiratory symptoms among children and adolescents in the United States was assessed. METHODS: Data were used from the Third National Health and Nutrition Examination Survey on infants aged 2 months through adolescents aged 16 years. DTP or tetanus vaccination, lifetime allergy history, and allergy symptoms in the past 12 months were based on parental or guardian recall. Logistic regression modeling was performed to estimate the effects of DTP or tetanus vaccination on each allergy. RESULTS: The odds of having a history of asthma was twice as great among vaccinated subjects than among unvaccinated subjects (adjusted odds ratio, 2.00; 95% confidence interval, 0.59 to 6.74). The odds of having had any allergy-related respiratory symptom in the past 12 months was 63% greater among vaccinated subjects than unvaccinated subjects (adjusted odds ratio, 1.63; 95% confidence interval, 1.05 to 2.54). The associations between vaccination and subsequent allergies and symptoms were greatest among children aged 5 through 10 years. CONCLUSIONS: DTP or tetanus vaccination appears to increase the risk of allergies and related respiratory symptoms in children and adolescents. Although it is unlikely that these results are entirely because of any sources of bias, the small number of unvaccinated subjects and the study design limit our ability to make firm causal inferences about the true magnitude of effect. PMID: 10714532 Int J Hyg Environ Health. 2001 Jul;203(5-6) :479-81.Inhibiti on of the human erythrocytic glutathione- S-transferase T1 (GST T1) by thimerosal. Müller M, Westphal G, Vesper A, Bünger J, Hallier E. Department of Occupational and Social Medicine, Georg-August- University Göttingen, D-37073 Göttingen, Germany. mmuelle3gwdg (DOT) de We have investigated the interaction of thimerosal, a widely used antiseptic and preservative, with the human erythrocytic GST T1 (glutathione- S-transferase T1). This detoxifying enzyme is expressed in the erythrocytes of solely the human species and it displays a genetic polymorphism. Due to this polymorphism about 25% of the individuals of the caucasian population lack this activity ( " non-conjugators " ), while 75% show it ( " conjugators " ) (Hallier, E., et al., 1993). Using our newly developed HPLC-fluorescence detection assay (Müller, M., et al., 2001) we have profiled the kinetics of enzyme inhibition in erythrocyte lysates of two individuals previously identified as " normal conjugator " (medium enzyme activity) and " super-conjugator " (very high activity). For the normal conjugator we have determined a 2.77 mM thimerosal concentration to inhibit 50% of the GST T1 activity. In the case of the super-conjugator a 2.3 mM thimerosal concentration causes a 50% inhibition of the enzyme activity. For both phenotypes a 14.8 mM thimerosal concentration results in residual enzyme activities equal to those typically detected in non-conjugator lysates. Thus, sufficiently high doses of thimerosal may be able to change the phenotypic status of an individual-- at least in vitro--by inhibition of the GST T1 enzyme. PMID: 11556154 Love, Gabby. :0) http://stemcellforautism.blogspot.com/ " I know of nobody who is purely Autistic or purely neurotypical. Even God had some Autistic moments, which is why the planets all spin. " ~ Jerry Newport Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.